Researchers are trying to determine if tracking seizure occurrence, seizure probability, behavioral state, cognition, and mood can be achieved using an implantable brain sensing and stimulation device (Medtronic RC+S Summit) coupled to an external, handheld, patient assistant device (PAD) with capability for patient interaction (patient data input). The system (RC+S \& PAD) provides intracranial EEG (iEEG) sensing, electrical brain stimulation, and machine learning algorithms running on the RC+S and PAD that will be coupled with electrical brain stimulation (EBS) to prevent seizures and improve quality of life in patients with epilepsy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Adverse events (AE) experienced with the RC+S system
Timeframe: Through 15 months
24/7 continuous iEEG monitoring
Timeframe: Through 15 months
Change in mood
Timeframe: Baseline, biweekly for up to 15 months
Change in anxiety
Timeframe: Baseline, biweekly for up to 15 months
Tracking cognition
Timeframe: Baseline, biweekly for up to 15 months